Annual Accounts Payable
$648.00 K
-$812.00 K-55.62%
December 31, 2023
Summary
- As of February 8, 2025, RANI annual accounts payable is $648.00 thousand, with the most recent change of -$812.00 thousand (-55.62%) on December 31, 2023.
- During the last 3 years, RANI annual accounts payable has risen by +$111.00 thousand (+20.67%).
- RANI annual accounts payable is now -55.62% below its all-time high of $1.46 million, reached on December 31, 2022.
Performance
RANI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.57 M
+$1.06 M+209.49%
September 30, 2024
Summary
- As of February 8, 2025, RANI quarterly accounts payable is $1.57 million, with the most recent change of +$1.06 million (+209.49%) on September 30, 2024.
- Over the past year, RANI quarterly accounts payable has increased by +$1.06 million (+209.49%).
- RANI quarterly accounts payable is now -95.50% below its all-time high of $34.82 million, reached on June 30, 2020.
Performance
RANI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RANI Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.6% | +209.5% |
| 3 y3 years | +20.7% | +209.5% |
| 5 y5 years | +227.3% | +209.5% |
RANI Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | at low | -12.5% | +209.5% |
| 5 y | 5-year | -55.6% | +227.3% | -95.5% | +209.5% |
| alltime | all time | -55.6% | +227.3% | -95.5% | +209.5% |
Rani Therapeutics Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.57 M(+209.5%) |
| Jun 2024 | - | $506.00 K(-37.2%) |
| Mar 2024 | - | $806.00 K(+24.4%) |
| Dec 2023 | $648.00 K(-55.6%) | $648.00 K(-53.9%) |
| Sep 2023 | - | $1.41 M(+35.5%) |
| Jun 2023 | - | $1.04 M(-31.4%) |
| Mar 2023 | - | $1.51 M(+3.5%) |
| Dec 2022 | $1.46 M | $1.46 M(-18.4%) |
| Sep 2022 | - | $1.79 M(+24.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.44 M(+13.8%) |
| Mar 2022 | - | $1.26 M(+17.1%) |
| Dec 2021 | $1.08 M(+101.1%) | $1.08 M(-17.6%) |
| Sep 2021 | - | $1.31 M(-21.4%) |
| Jun 2021 | - | $1.67 M(+76.8%) |
| Mar 2021 | - | $943.00 K(+75.6%) |
| Dec 2020 | $537.00 K(+171.2%) | $537.00 K(-98.3%) |
| Sep 2020 | - | $32.12 M(-7.8%) |
| Jun 2020 | - | $34.82 M |
| Dec 2019 | $198.00 K | - |
FAQ
- What is Rani Therapeutics Holdings annual accounts payable?
- What is the all time high annual accounts payable for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings annual accounts payable year-on-year change?
- What is Rani Therapeutics Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings quarterly accounts payable year-on-year change?
What is Rani Therapeutics Holdings annual accounts payable?
The current annual accounts payable of RANI is $648.00 K
What is the all time high annual accounts payable for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high annual accounts payable is $1.46 M
What is Rani Therapeutics Holdings annual accounts payable year-on-year change?
Over the past year, RANI annual accounts payable has changed by -$812.00 K (-55.62%)
What is Rani Therapeutics Holdings quarterly accounts payable?
The current quarterly accounts payable of RANI is $1.57 M
What is the all time high quarterly accounts payable for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high quarterly accounts payable is $34.82 M
What is Rani Therapeutics Holdings quarterly accounts payable year-on-year change?
Over the past year, RANI quarterly accounts payable has changed by +$1.06 M (+209.49%)